Nursing Pharmacology:  Antiviral Drugs

• Antiviral Drugs

  • Anti-viral drugs with activity against HIV (Human Immunodeficiency Virus)

    • HIV-1 Pathophysiology/Pathogenesis:  HIV Disease Presentations

      HIV Effects on the Gastrointestinal System (continued):

      • Protozoal Infections:

        •  Microsporidia²

          • Microsporidia are unicellular, intracellular parasites associated with enteric (gastrointestinal) cell cytoplasm.

            • In humans the main species resulting in disease is Enterocytozoon bienuesi.

            • Clinical presentation is comparable to that seen with cryptosporidia including:

              • Diarrhea

              • Abdominal pain

              • Malabsorption

              • Cholangitis

            • Diagnosis may utilize intestinal aspirate, intestinal biopsy or even electrom microscopic examination of stool.²  

          • Microsporidia has also been found in extraintestinal sites such as eye, brain, muscle, sinuses, and liver.

            • In the eye this parasite appears associated with conjunctivitis and in the liver appears associated with hepatitis.

            • In an example catchment group, from the Czech Republic, seropositivity for Enterocytozoon bienuesi was assessed.⁸ 

              • 115 serum samples from different groups were tested for seropositivity.⁸  

                • 20% of samples from HIV-positive individuals were positive for Enterocytozoon bienuesi .

                • About 33% of individuals with occupational exposure to animals tested positive and overall about 10% seropositivity was identified from healthy individuals.

                • The assessment method depended on an indirect immunofluorescence assay.⁸ 

          • Microsporidial infection in HIV patients may be most effectively managed by administration of cART (HAART) i.e., highly active combination anti-retroviral drugs.

        •  Isospora belli:

          • Isospora belli, a coccidian parasite, is usually found as a cause of diarrhea in individuals from tropical and subtropical regions.² 

            • Isospora belli¹⁰

              Van den Enden, E Illustrated Lecture Notes on Tropical medicine:  HIV and AIDS-Opportunistic infections, treatment

            • Infection occurs as a result of oocyst ingestion.⁹ 

            • The parasite then invades intestinal epithelial cells and proceeds through development cycles.

            • In immunocompromised patients, including AIDS patients, Isospora belli infections may not be self-limited, instead resembling cryptosporidosis with chronic, watery diarrhea.

              • Eosinophilia, not found in other enteric protozoan infections, may be noted with I. belli.⁹ 

      • CMV Colitis

        • Colitis as a result of cytomegaloviral (CMV) infection had been observed in about 5%-10% of AIDS patients prior to the advent of cART (HAART) therapy.

          • Patients receiving contemporary combinations of anti-retroviral drugs are much less likely to experience CMV colitis.

            • CMV colitis is however associated with diarrhea, weight loss, abdominal pain and anorexia.

            • Diagnosis may be obtained through endoscopy and biopsy with endoscopy revealing multiple mucosal alterations and biopsies showing intra-nuclear and cytoplasmic inclusions. As a result of bowel wall thinning, secondary bacteremias may occur.

      • An algorithm for diagnosis and management of diarrhea in patients infected with HIV has been described:

        •  

          "Diagnosis and Management of HIV-Associated Diarrhea"11

          "Basic algorithm for the diagnosis and management of human immunodeficiency virus-associated diarrhea. Diarrhea was defined as the abnormal passage of loose or liquid stools ≥ 3 times a day, and/or a liquid stool volume of >200 g/d.. Upper endoscopy and colonoscopy should be strongly considered for patients with CD4+ cell counts <100 cells/µL. Abbreviations: HAART, highly active antiretroviral therapy; HIV, human immunodeficiency virus." MacArthur RD DuPont HL Etiology and Pharmacologic Management of Noninfectious Diarrhea in HIV-Infected Individuals in the Highly Active Antiretroviral Therapy Era (Reviews of Anti-infective Agents, Invited Article) Clinic Infectious Diseases 56(6):  860-867 2012. http://www.natap.org/2013/HIV/ClinInfectDis.-2012--860-7.pdf The figure above corresponds to Figure 1 in reference 11.

References

Flexner C Antiretroviral Agents and Treatment of HIV Infection, Chapter 59  in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edition (Brunton LL Chabner BA Knollmann BC, eds; Brunton LL, ed; Blumenthal DK  Murri N Hilal-Dandan R, assoc eds, Knollmann BC, consulting ed, on-line edition) The McGraw-Hill Companies, 2011. Fauci AS Lane HC Chapter 189, Human Immunodeficiency Virus Disease:  AIDS and Related Disorders, in Harrison's Online   (Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 18th edition, The McGraw-Hill Companies, Inc. 2012. Longo DL Fauci AS  188, The Human Retroviruses, in Harrison's Online   (Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 18th edition, The McGraw-Hill Companies, Inc. 2012. Woster PM Chapter 43:  Antiviral Agents and Protease Inhibitors in Foye's Principles of Medicinal Chemistry 6e, Lemke, TL Williams DA, eds; Roche VG Zito SW, asst eds) Wolters Kluwer|Lippincott Williams & Wilkins 1214, 2008. Knox TA Wanke C Gastrointestinal Manifestations of HIV and AIDS  Chapter 397, pp 2196-2199 Goldman's Cecil Medicine 24e (Goldman L and Schafer AI, eds) Elsevier/Saunders, 2012. Lima AAM Guerrant RL Cryptosporidosis Chapter 358, 2038-3040 Goldman's Cecil Medicine 24e (Goldman L and Schafer AI, eds) Elsevier/Saunders, 2012. DPDx-Laboratory Identification of Parasitic Disease of Public Health Concern:  Centers for Disease Control (CDC).  Microsporidiosis, Parasite Biology. http://www.cdc.gov/dpdx/microsporidiosis/ Sak B Kucerova Z Kvac M Kvetonova D Rost M Secor EW Seropositivity for Enterocytozoon bienuesi, Czech Republic.  Emerging Infectious Diseases 16(2) 325-337, 2010. http://wwwnc.cdc.gov/eid/article/16/2/pdfs/09-0964.pdf Weller PF Chapter 215, Protozoal Infections and Trichomoniasis in in Harrison's Online   (Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 18th edition, The McGraw-Hill Companies, Inc. 2012. Van den Enden E  Illustrated Lecture Notes on Tropical medicine:  HIV and AIDS-Opportunistic infections, treatment. http://itg.content-e.eu/Generated/pubx/173/hiv_and_aids/opportunistic_infections_treatment.htm (Institute of Tropical Medicine, Antwerp) MacArthur RD DuPont HL Etiology and Pharmacologic Management of Noninfectious Diarrhea in HIV-Infected Individuals in the Highly Active Antiretroviral Therapy Era (Reviews of Anti-infective Agents, Invited Article) Clinic Infectious Diseases 56(6):  860-867 2012. http://www.natap.org/2013/HIV/ClinInfectDis.-2012--860-7.pdf

 

Disclaimer

This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.